Pittenger & Anderson Inc’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.09M | Sell |
3,003
-30
| -1% | -$10.3K | 0.04% | 163 |
|
|
2026
Q1 | $1.07M | Buy |
3,033
+60
| +2% | +$21.4K | 0.04% | 166 |
|
|
2025
Q4 | $973K | Buy |
2,973
+90
| +3% | +$28.5K | 0.04% | 171 |
|
|
2025
Q3 | $814K | Buy |
2,883
+23
| +0.8% | +$6.67K | 0.03% | 176 |
|
|
2025
Q2 | $799K | Buy |
2,860
+400
| +16% | +$113K | 0.03% | 166 |
|
|
2025
Q1 | $766K | Hold |
2,460
| – | – | 0.03% | 164 |
|
|
2024
Q4 | $641K | Hold |
2,460
| – | – | 0.02% | 175 |
|
|
2024
Q3 | $793K | Hold |
2,460
| – | – | 0.03% | 164 |
|
|
2024
Q2 | $769K | Hold |
2,460
| – | – | 0.03% | 165 |
|
|
2024
Q1 | $699K | Hold |
2,460
| – | – | 0.03% | 168 |
|
|
2023
Q4 | $709K | Hold |
2,460
| – | – | 0.03% | 167 |
|
|
2023
Q3 | $661K | Sell |
2,460
-300
| -11% | -$74.9K | 0.03% | 158 |
|
|
2023
Q2 | $613K | Hold |
2,760
| – | – | 0.03% | 160 |
|
|
2023
Q1 | $667K | Hold |
2,760
| – | – | 0.03% | 156 |
|
|
2022
Q4 | $725K | Hold |
2,760
| – | – | 0.04% | 146 |
|
|
2022
Q3 | $622K | Hold |
2,760
| – | – | 0.04% | 142 |
|
|
2022
Q2 | $672K | Sell |
2,760
-14
| -0.5% | -$3.43K | 0.04% | 148 |
|
|
2022
Q1 | $671K | Sell |
2,774
-1,551
| -36% | -$356K | 0.03% | 152 |
|
|
2021
Q4 | $973K | Sell |
4,325
-33,982
| -89% | -$7.17M | 0.04% | 146 |
|
|
2021
Q3 | $8.15M | Sell |
38,307
-564
| -1% | -$130K | 0.41% | 73 |
|
|
2021
Q2 | $9.47M | Buy |
38,871
+281
| +0.7% | +$69.1K | 0.49% | 63 |
|
|
2021
Q1 | $9.6M | Buy |
38,590
+2,652
| +7% | +$633K | 0.52% | 57 |
|
|
2020
Q4 | $8.26M | Buy |
35,938
+411
| +1% | +$94.8K | 0.47% | 63 |
|
|
2020
Q3 | $9.03M | Buy |
35,527
+543
| +2% | +$135K | 0.58% | 50 |
|
|
2020
Q2 | $8.25M | Buy |
34,984
+367
| +1% | +$83.7K | 0.58% | 50 |
|
|
2020
Q1 | $7.02M | Buy |
34,617
+362
| +1% | +$79.1K | 0.6% | 43 |
|
|
2019
Q4 | $8.26M | Sell |
34,255
-117
| -0.3% | -$25.8K | 0.55% | 46 |
|
|
2019
Q3 | $6.65M | Sell |
34,372
-207
| -0.6% | -$39.7K | 0.48% | 61 |
|
|
2019
Q2 | $6.37M | Buy |
34,579
+2,370
| +7% | +$424K | 0.48% | 62 |
|
|
2019
Q1 | $6.12M | Buy |
32,209
+657
| +2% | +$125K | 0.48% | 61 |
|
|
2018
Q4 | $6.14M | Buy |
31,552
+612
| +2% | +$119K | 0.56% | 51 |
|
|
2018
Q3 | $6.41M | Buy |
30,940
+900
| +3% | +$177K | 0.51% | 59 |
|
|
2018
Q2 | $5.54M | Buy |
30,040
+2,605
| +9% | +$461K | 0.47% | 61 |
|
|
2018
Q1 | $4.68M | Buy |
27,435
+4,052
| +17% | +$744K | 0.41% | 69 |
|
|
2017
Q4 | $4.07M | Buy |
23,383
+125
| +0.5% | +$22.1K | 0.36% | 79 |
|
|
2017
Q3 | $4.34M | Sell |
23,258
-235
| -1% | -$41.6K | 0.39% | 70 |
|
|
2017
Q2 | $4.05M | Sell |
23,493
-1,912
| -8% | -$311K | 0.39% | 71 |
|
|
2017
Q1 | $4.17M | Buy |
25,405
+500
| +2% | +$83.1K | 0.42% | 63 |
|
|
2016
Q4 | $3.64M | Sell |
24,905
-835
| -3% | -$126K | 0.39% | 69 |
|
|
2016
Q3 | $4.29M | Buy |
25,740
+3,510
| +16% | +$594K | 0.48% | 56 |
|
|
2016
Q2 | $3.38M | Buy |
22,230
+6,255
| +39% | +$972K | 0.37% | 71 |
|
|
2016
Q1 | $2.4M | Buy |
15,975
+440
| +3% | +$65.4K | 0.28% | 96 |
|
|
2015
Q4 | $2.52M | Buy |
15,535
+5,460
| +54% | +$858K | 0.32% | 91 |
|
|
2015
Q3 | $1.39M | Buy |
10,075
+1,325
| +15% | +$209K | 0.18% | 135 |
|
|
2015
Q2 | $1.34M | Buy |
8,750
+1,450
| +20% | +$232K | 0.17% | 140 |
|
|
2015
Q1 | $1.17M | Buy |
+7,300
| New | +$1.15M | 0.15% | 155 |
|
Other funds holding AMGN
Pittenger & Anderson Inc's AMGN Position: Q2 2026 in Review
Pittenger & Anderson Inc reduced its Amgen (AMGN) stake by 0.99% in Q2 2026, selling an estimated $10.3K and leaving 3,003 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #163.
Pittenger & Anderson Inc first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $9.6M in Q1 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Pittenger & Anderson Inc held 3,003 shares of Amgen worth $1.09M as of Q2 2026.
- Pittenger & Anderson Inc sold 30 Amgen shares in Q2 2026, an estimated $10.3K.
- Amgen made up 0.04% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #163 holding.
- Pittenger & Anderson Inc first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
- Pittenger & Anderson Inc's Amgen position peaked at $9.6M in Q1 2021.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.